{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:09:09Z","timestamp":1784920149441,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11255-016-1436-3","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T08:50:12Z","timestamp":1477990212000},"page":"273-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument"],"prefix":"10.1007","volume":"49","author":[{"given":"Nigar","family":"Sekercioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Al-Khalifah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joycelyne Efua","family":"Ewusie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosilene M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noori","family":"Akhtar-Danesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Isayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo D\u00edaz","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan D.","family":"Florez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"issue":"9888","key":"1436_CR1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K et al (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260\u2013272","journal-title":"Lancet"},{"key":"1436_CR2","unstructured":"National Institutes of Health NIoDaDaKD (2015) United States renal data system. 2015 USRDS annual data report: epidemiology of kidney disease in the United States. United States Renal Data System, Bathesda"},{"issue":"5","key":"1436_CR3","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/01.ASN.0000125670.64996.BB","volume":"15","author":"DH Smith","year":"2004","unstructured":"Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB (2004) Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol: JASN 15(5):1300\u20131306","journal-title":"J Am Soc Nephrol: JASN"},{"issue":"3","key":"1436_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","volume":"72","author":"AS Levey","year":"2007","unstructured":"Levey AS, Atkins R, Coresh J et al (2007) Chronic kidney disease as a global public health problem: approaches and initiatives\u2014a position statement from kidney disease improving global outcomes. Kidney Int 72(3):247\u2013259","journal-title":"Kidney Int"},{"issue":"6","key":"1436_CR5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3747\/pdi.2011.00274","volume":"33","author":"L Cortes-Sanabria","year":"2013","unstructured":"Cortes-Sanabria L, Rodriguez-Arreola BE, Ortiz-Juarez VR et al (2013) Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis. Perit Dial Int: J Int Soc Perit Dial 33(6):679\u2013686","journal-title":"Perit Dial Int: J Int Soc Perit Dial"},{"issue":"2","key":"1436_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0975-7406.94810","volume":"4","author":"A Suja","year":"2012","unstructured":"Suja A, Anju R, Anju V, Neethu J, Peeyush P, Saraswathy R (2012) Economic evaluation of end stage renal disease patients undergoing hemodialysis. J Pharm Bioallied Sci 4(2):107\u2013111","journal-title":"J Pharm Bioallied Sci"},{"issue":"4","key":"1436_CR7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18553\/jmcp.2009.15.4.312","volume":"15","author":"F Laliberte","year":"2009","unstructured":"Laliberte F, Bookhart BK, Vekeman F et al (2009) Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm: JMCP 15(4):312\u2013322","journal-title":"J Manag Care Pharm: JMCP"},{"issue":"3","key":"1436_CR8","first-page":"1","volume":"2013","author":"Group KDIGOKCW: KDIGO","year":"2012","unstructured":"Group KDIGOKCW: KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013(3):1\u2013150","journal-title":"Kidney Int"},{"key":"1436_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","volume":"36","author":"SM Moe","year":"2006","unstructured":"Moe SM (2006) Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest 36:51\u201362","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"1436_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.nefro.2015.05.017","volume":"35","author":"C Sanchez-Perales","year":"2015","unstructured":"Sanchez-Perales C, Vazquez Ruiz de Castroviejo E, Garcia-Cortes MJ, Biechy Mdel M, Gil-Cunquero JM, Borrego-Hinojosa J et al (2015) Valvular calcifications at the start of dialysis predict the onset of cardiovascular events in the course of follow-up. Nefrologia 35(2):157\u2013163. doi: 10.1016\/j.nefro.2015.05.017","journal-title":"Nefrologia"},{"key":"1436_CR11","first-page":"1","volume":"19","author":"D Rebic","year":"2015","unstructured":"Rebic D, Rasic C (2015) Valvular calcification and left ventricular modifying in peritoneal dialysis patients. Renal Fail 19:1\u20137","journal-title":"Renal Fail"},{"key":"1436_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40697-40015-40065-40696","volume":"2","author":"TJ Wilkieson","year":"2015","unstructured":"Wilkieson TJ (2015) Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on hemodialysis. Can J Kidney Health Dis 2:29. doi: 10.1186\/s40697-40015-40065-40696 (eCollection 42015)","journal-title":"Can J Kidney Health Dis"},{"issue":"6","key":"1436_CR13","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ndt\/gfl840","volume":"22","author":"MD Arenas","year":"2007","unstructured":"Arenas MD, Alvarez-Ude F, Gil MT et al (2007) Implementation of \u2018K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease\u2019 after the introduction of cinacalcet in a population of patients on chronic haemodialysis. Nephrol Dial Transpl 22(6):1639\u20131644","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"1436_CR14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneph0977","volume":"5","author":"JB Wetmore","year":"2009","unstructured":"Wetmore JB, Quarles LD (2009) Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nat Clin Pract Nephrol 5(1):24\u201333","journal-title":"Nat Clin Pract Nephrol"},{"issue":"4","key":"1436_CR15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6(4):913\u2013921","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1436_CR16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","volume":"89","author":"SC Pitt","year":"2009","unstructured":"Pitt SC, Sippel RS, Chen H (2009) Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin N Am 89(5):1227\u20131239","journal-title":"Surg Clin N Am"},{"key":"1436_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S78040","volume":"9","author":"V Cernaro","year":"2016","unstructured":"Cernaro V, Santoro D, Lacquaniti A et al (2016) Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. Int J Nephrol Renovasc Dis 9:11\u201319","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"9900","key":"1436_CR18","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897","volume":"382","author":"Jamal","year":"2013","unstructured":"Jamal et al (2013) Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382(9900):1268\u20131277. doi: 10.1016\/S0140-6736(13)60897","journal-title":"Lancet"},{"issue":"3","key":"1436_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11255-014-0876-x","volume":"47","author":"CJ Zhai","year":"2015","unstructured":"Zhai CJ et al (2015) Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol 47(3):527\u2013535. doi: 10.1007\/s11255-014-0876-x","journal-title":"Int Urol Nephrol"},{"key":"1436_CR20","first-page":"06800615","volume":"14","author":"L Patel","year":"2015","unstructured":"Patel L, Bernard M (2015) Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials. Clin J Am Soc Nephrol 14:06800615","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1436_CR21","first-page":"33","volume":"22","author":"C Meyer","year":"2012","unstructured":"Meyer C, Cameron K, Battistella M (2012) New agent to treat elevated phosphate levels: magnesium carbonate\/calcium carbonate tablets. CANNT J J ACITN 22(4):33\u201335 quiz 36-37","journal-title":"CANNT J J ACITN"},{"key":"1436_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13012-014-0172-2","volume":"9","author":"B Field","year":"2014","unstructured":"Field B, Booth A, Ilott I, Gerrish K (2014) Using the knowledge to action framework in practice: a citation analysis and systematic review. Implement Sci: IS 9:172","journal-title":"Implement Sci: IS"},{"issue":"3","key":"1436_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/intqhc\/mzi027","volume":"17","author":"J Vlayen","year":"2005","unstructured":"Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D (2005) A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care 17(3):235\u2013242. doi: 10.1093\/intqhc\/mzi027","journal-title":"Int J Qual Health Care"},{"issue":"5","key":"1436_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ypmed.2010.08.005","volume":"51","author":"II Agree","year":"2010","unstructured":"AGREE II (2010) Advancing guideline development, reporting, and evaluation in health care. Prev Med 51(5):421\u2013424. doi: 10.1016\/j.ypmed.2010.08.005","journal-title":"Prev Med"},{"key":"1436_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/intqhc\/11.1.21","volume":"11","author":"FA Cluzeau","year":"1999","unstructured":"Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G, Moran SE (1999) Development and application of a generic methodology to asess the quality of clinical guidelines. Int J Qual Health Care 11:21\u201328","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"1436_CR26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2753.2012.01873.x","volume":"19","author":"J Yan","year":"2013","unstructured":"Yan J, Min J, Zhou B (2013) Diagnosis of pheochromocytoma: a clinical practice guideline appraisal using AGREE II instrument. J Eval Clin Pract 19(4):626\u2013632","journal-title":"J Eval Clin Pract"},{"issue":"4","key":"1436_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jvs.2015.12.040","volume":"63","author":"AM Barriocanal","year":"2016","unstructured":"Barriocanal AM, Lopez A, Monreal M, Montane E (2016) Quality assessment of peripheral artery disease clinical guidelines. J Vasc Surg 63(4):1091\u20131098","journal-title":"J Vasc Surg"},{"issue":"5","key":"1436_CR28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1053\/j.ajkd.2010.02.339","volume":"55","author":"BJ Manns","year":"2010","unstructured":"Manns BJ, Hodsman A, Zimmerman DL et al (2010) Canadian society of nephrology commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 55(5):800\u2013812","journal-title":"Am J Kidney Dis"},{"issue":"4 Suppl 3","key":"1436_CR29","first-page":"S1","volume":"42","author":"National Kideny Foudation","year":"2003","unstructured":"National Kideny Foudation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1\u2013201","journal-title":"Am J Kidney Dis"},{"key":"1436_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.188","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. doi: 10.1038\/ki.2009.188","journal-title":"Kidney Int"},{"key":"1436_CR31","unstructured":"Centre for Clinical Practice at N (2013) National Institute for Health and Clinical Excellence: Guidance. Hyperphosphataemia in chronic kidney disease: management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease. National Institute for Health and Clinical Excellence (UK)Copyright (c) National Institute for Health and Clinical Excellence, Manchester"},{"key":"1436_CR32","unstructured":"(2014) Hyperphosphataemia in chronic kidney disease evidence update December 2014. NICE guidelines"},{"issue":"Suppl 1","key":"1436_CR33","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/j.1440-1797.2010.01233.x","volume":"15","author":"S Chadban","year":"2010","unstructured":"Chadban S, Chan M, Fry K et al (2010) The CARI guidelines. Nutritional interventions for the prevention of bone disease in kidney transplant recipients. Nephrology (Carlton, Vic) 15(Suppl 1):S43\u2013S47","journal-title":"Nephrology (Carlton, Vic)"},{"issue":"Suppl 1","key":"1436_CR34","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1111\/j.1440-1797.2006.00508.x","volume":"11","author":"G Elder","year":"2006","unstructured":"Elder G, Faull R, Branley P, Hawley C (2006) The CARI guidelines. Management of bone disease, calcium, phosphate and parathyroid hormone. Nephrology (Carlton, Vic) 11(Suppl 1):S230\u2013S261","journal-title":"Nephrology (Carlton, Vic)"},{"issue":"Suppl 1","key":"1436_CR35","first-page":"S198","volume":"11","author":"C Hawley","year":"2006","unstructured":"Hawley C, Elder G (2006) The CARI guidelines. Biochemical targets. Nephrology (Carlton, Vic) 11(Suppl 1):S198\u2013S216","journal-title":"Nephrology (Carlton, Vic)"},{"key":"1436_CR36","doi-asserted-by":"crossref","unstructured":"Section IV. bone disease (2002) Nephrology Dialysis Transplantation, vol 17, pp 43\u201348. http:\/\/resolver.scholarsportal.info\/resolve\/09310509\/v17inone_s4\/43_ibd","DOI":"10.1093\/ndt\/17.suppl_4.43"},{"key":"1436_CR37","unstructured":"Stedon S, Sharples E (2015) Clinical practice guideline CKD-mineral and bone disorders (CKD-MBD). http:\/\/www.renal.org\/docs\/default-source\/default-document-library\/ra-ckd-mbd-finalversion-2015-v2870fa131181561659443ff000014d4d8.pdf?sfvrsn=0"},{"issue":"3","key":"1436_CR38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Yokoyama K, Koiwa F et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apheresis Dial 17(3):247\u2013288","journal-title":"Ther Apheresis Dial"},{"issue":"3 Suppl 1","key":"1436_CR39","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.2005121372","volume":"17","author":"K Jindal","year":"2006","unstructured":"Jindal K, Chan CT, Deziel C et al (2006) Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol: JASN 17(3 Suppl 1):S1\u201327","journal-title":"J Am Soc Nephrol: JASN"},{"issue":"11","key":"1436_CR40","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1503\/cmaj.080351","volume":"179","author":"A Levin","year":"2008","unstructured":"Levin A, Hemmelgarn B, Culleton B et al (2008) Guidelines for the management of chronic kidney disease. CMAJ. Can Med Assoc J 179(11):1154\u20131162","journal-title":"CMAJ. Can Med Assoc J"},{"issue":"Suppl 1","key":"1436_CR41","first-page":"1","volume":"28","author":"JV Torregrosa","year":"2008","unstructured":"Torregrosa JV, Cannata Andia J, Bover J et al (2008) SEN guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients. Nefrologia 28(Suppl 1):1\u201322","journal-title":"Nefrologia"},{"issue":"3","key":"1436_CR42","first-page":"108","volume":"32","author":"MD Prados-Garrido","year":"2011","unstructured":"Prados-Garrido MD, Bover J, Teresa Gonz\u00e1lez-\u00c1lvarez M (2011) Clinical practice guideline for chronic kidney disease-mineral and bone disease (2010 version). Dialisis Transplante 32(3):108\u2013118","journal-title":"Dialisis Transplante"},{"issue":"Suppl 37","key":"1436_CR43","first-page":"S107","volume":"24","author":"S Mazzaferro","year":"2007","unstructured":"Mazzaferro S, Cozzolino M, Marangella M, Strippoli GF, Messa P (2007) Calcimimetics, phosphate binders, vitamin D and its analogues for treating secondary hyperparathyroidism in chronic kidney disease: guideline from the Italian Society of Nephrology. Giornale italiano di nefrologia 24(Suppl 37):S107\u2013S124","journal-title":"Giornale italiano di nefrologia"},{"issue":"2","key":"1436_CR44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1590\/S0101-28002012000200015","volume":"34","author":"AB Carvalho","year":"2012","unstructured":"Carvalho AB, Gueiros AP, Gueiros JE et al (2012) Guidelines on bone mineral disorder in chronic kidney disease\u2013addendum chapter 2. Jornal brasileiro de nefrologia 34(2):199\u2013205","journal-title":"Jornal brasileiro de nefrologia"},{"issue":"3","key":"1436_CR45","first-page":"121","volume":"15","author":"Anonymous","year":"2009","unstructured":"Anonymous (2009) Guidelines of the Ministry of Health of the Slovak Republic for the treatment of bone and mineral metabolism disorders in patients with chronic kidney disease. Aktuality v Nefrologii 15(3):121\u2013127","journal-title":"Aktuality v Nefrologii"},{"issue":"2","key":"1436_CR46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Oxman AD, Santesso N et al (2013) GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 66(2):158\u2013172","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"1436_CR47","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed.) 336(7650):924\u2013926","journal-title":"BMJ (Clinical research ed.)"},{"issue":"9","key":"1436_CR48","first-page":"1094","volume":"16","author":"KB Zarnke","year":"2000","unstructured":"Zarnke KB, Campbell NR, McAlister FA, Levine M (2000) A novel process for updating recommendations for managing hypertension: rationale and methods. Can J Cardiol 16(9):1094\u20131102","journal-title":"Can J Cardiol"},{"issue":"13","key":"1436_CR49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jama.2014.10713","volume":"312","author":"B Djulbegovic","year":"2014","unstructured":"Djulbegovic B, Guyatt GH (2014) Evidence-based practice is not synonymous with delivery of uniform health care. JAMA 312(13):1293\u20131294","journal-title":"JAMA"},{"issue":"9","key":"1436_CR50","doi-asserted-by":"crossref","first-page":"e0137180","DOI":"10.1371\/journal.pone.0137180","volume":"10","author":"CA Smith","year":"2015","unstructured":"Smith CA, Toupin-April K, Jutai JW et al (2015) A systematic critical appraisal of clinical practice guidelines in juvenile idiopathic arthritis using the appraisal of guidelines for research and evaluation II (AGREE II) instrument. PLoS One 10(9):e0137180","journal-title":"PLoS One"},{"issue":"5","key":"1436_CR51","doi-asserted-by":"crossref","first-page":"e95369","DOI":"10.1371\/journal.pone.0095369","volume":"9","author":"L Brosseau","year":"2014","unstructured":"Brosseau L, Rahman P, Poitras S et al (2014) A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with appraisal of guidelines for research and evaluation II. PLoS One 9(5):e95369","journal-title":"PLoS One"},{"issue":"1","key":"1436_CR52","doi-asserted-by":"crossref","first-page":"e82986","DOI":"10.1371\/journal.pone.0082986","volume":"9","author":"L Brosseau","year":"2014","unstructured":"Brosseau L, Rahman P, Toupin-April K et al (2014) A systematic critical appraisal for non-pharmacological management of osteoarthritis using the appraisal of guidelines research and evaluation II instrument. PLoS One 9(1):e82986","journal-title":"PLoS One"},{"issue":"11","key":"1436_CR53","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jclinepi.2014.07.005","volume":"67","author":"GS Hazlewood","year":"2014","unstructured":"Hazlewood GS, Akhavan P, Schieir O et al (2014) Adding a \u201cGRADE\u201d to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II. J Clin Epidemiol 67(11):1274\u20131285","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1436_CR54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/intqhc\/mzi027","volume":"17","author":"J Vlayen","year":"2005","unstructured":"Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D (2005) A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care 17(3):235\u2013242","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"1436_CR55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1373\/clinchem.2005.056952","volume":"52","author":"J Watine","year":"2006","unstructured":"Watine J, Friedberg B, Nagy E et al (2006) Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners. Clin Chem 52(1):65\u201372","journal-title":"Clin Chem"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1436-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-016-1436-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1436-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T22:25:48Z","timestamp":1657578348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-016-1436-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1436"],"URL":"https:\/\/doi.org\/10.1007\/s11255-016-1436-3","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}